NEW YORK (
was the biggest gainer among small-caps Monday afternoon, its shares soaring 55% to $23.30, after U.S. regulators approved its major depressive disorder treatment Viibryd. The biotech company said the drug would be available in U.S. pharmacies by the second quarter. Over 9 million shares changed hands.
jumped 26% to $24.83 on heavy volumes after Swiss pharma giant
said it was acquiring the diagnostics laboratory for $470 million or $25 per share in an all cash deal.
shot up 20% to $1.57 after Israel-based
said it had acquired a 6% stake in the company at $1.69 per share.
Several solar stocks were shining on the bourses after Goldman Sachs added
(FSLR - Get Report)
to its conviction list. Shares of
were surging 10.5% to $14.53.
(TSL - Get Report)
(SOL - Get Report)
were also up sharply.
were recovering Monday after plunging last week, rising 7.2% to $6.23. The stock took a hit last week after it said that
was reluctant to market its pain reliever drug.
Level 3 Communications
Dot Hill Systems
ATP Oil and Gas
were among the other major gainers on Monday.
-- Written by Shanthi Bharatwaj in New York
>To contact the writer of this article, click here:
>To follow the writer on Twitter, go to
>To submit a news tip, send an email to: